In particular, CDKN2A is overexpressed in bone marrow mesenchymal stromal cells (BM-MSCs) in patients with MDS, and CDKN2A knockdown can promote the proliferation of BM-MSCs (38). The gene discussed is CDKN2A; the disease is myelodysplastic syndrome.